18 December 2025
Latham & Watkins Advises on Immunome’s US$400 Million Public Offering
Advising firms
Deal team
5 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Matt Bush Lead | Latham & Watkins LLP | Partner | Capital Markets | San Diego |
| Anthony Gostanian | Latham & Watkins LLP | Counsel | Capital Markets | Not stated |
| Raul Gonzalez-Casarrubias | Latham & Watkins LLP | Associate | Capital Markets | Not stated |
| Sterling Swift | Latham & Watkins LLP | Associate | Capital Markets | Not stated |
| Ivana Valdez | Latham & Watkins LLP | Associate | Capital Markets | Not stated |
2 more lawyers on this deal. Register free to see the full deal team, with seniority, practice and office.
REGISTER FREE SIGN INWant co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.
Stated terms
- Stated value
- USD 400m (US$400 Million)
- What the figure measures
- Issue size
- Client
- Not stated
- Counterparties
- Immunome, Inc. (Issuer)